AA

Abhay Agrawal

Active Director Director DIN 07005258
DIN 07005258 First appointment Jan 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Jan 2015
Shareholding value •••• Premium profile

About Abhay Agrawal

Data last updated:

Abhay Agrawal is a Director at Q-Line Biotech Limited (since 2015), Director at Heidelco Medicore Private Limited (since 2016) and Director at Poct Quality & Skill Development Foundation (since 2019), and holds 1 more current directorship. The companies operate in Healthcare and Education. The 3 current companies with reported revenue have a combined latest revenue of ₹373 Cr; the largest is Q-Line Biotech Limited at ₹322 Cr (FY 2025).

DIN 07005258
Primary Designation Director
Industry Healthcare
First Appointment 12 Jan 2015
Oldest Company Age 16 yrs
Largest company Q-Line Biotech Limited · ₹322 Cr (FY 2025)
Combined revenue ₹373 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Q-Line Biotech Limited U74120UP2010PLC042528
Director12 Jan 20152010₹322 Cr (FY 2025)Active
Heidelco Medicore Private Limited U52100UP2013PTC056558
Director10 Feb 20162013₹51.23 Cr (FY 2024)Active
Director23 Dec 20192018₹4.2 Lakh (FY 2024)Active
Patheasy Diagnostics Private Limited U86905UP2025PTC228672
Director25 Jul 20252025Active

Directorship timeline

Open interactive timeline →
Heidelco Medicore Private Limited
Poct Quality & Skill Development Foundation
Q-Line Biotech Limited
Patheasy Diagnostics Private Limited
Premium access

Shareholding and investment profile for Abhay Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhay Agrawal

Abhay Agrawal currently holds 4 directorships: Q-Line Biotech Limited (Director, since 12 Jan 2015, revenue ₹322 Cr (FY 2025)); Heidelco Medicore Private Limited (Director, since 10 Feb 2016, revenue ₹51.23 Cr (FY 2024)); Poct Quality & Skill Development Foundation (Director, since 23 Dec 2019, revenue ₹4.2 Lakh (FY 2024)); Patheasy Diagnostics Private Limited (Director, since 25 Jul 2025).

Abhay Agrawal was first appointed on 12 Jan 2015 as Director at Q-Line Biotech Limited. The most recent appointment on record is 25 Jul 2025 at Patheasy Diagnostics Private Limited.

The 3 current companies of Abhay Agrawal that report revenue have a combined latest revenue of ₹373 Cr: Q-Line Biotech Limited ₹322 Cr (FY 2025); Heidelco Medicore Private Limited ₹51.23 Cr (FY 2024); Poct Quality & Skill Development Foundation ₹4.2 Lakh (FY 2024).

The current boards of Abhay Agrawal's companies include Abhishek Mishra (Q-Line Biotech Limited), Ajay Kumar Mahanty (Q-Line Biotech Limited), Akhand Pratap Singh (Q-Line Biotech Limited), Amita Garg (Q-Line Biotech Limited), Ayush Garg (Q-Line Biotech Limited), Jai Prakash Singh (Q-Line Biotech Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available